Melanotan 1 Community Reports
What do these badges mean?
Evidence tier
- AHuman-validated — Human trials showing positive results and good safety.
- BAnimal-grade — No human trials yet, but solid animal/preclinical evidence of effect and safety.
- CAnecdotal — No human or animal trials — only anecdotal/observational reports.
- DInsufficient evidence — No or insufficient evidence (encyclopedia only — never recommended by the builder).
Safety light
- 🟢 Green — Only mild, manageable side effects; reasonable safety data.
- 🟡 Yellow — Needs active management, has a meaningful contraindication/interaction, or has thin long-term data.
- 🔴 Red — Risk of a hospital-level event — treat with serious caution.
Browse-only — not on the protocol builder's curated shortlist, so the builder won't recommend it.
How can it help me?
Wiki article — community perspective
Companion raw digest:
Evidence tier: throughout
Last updated: 2026-07-10
Cross-refs: *peptides/melanotan-2* · *peptides/pt-141*
The full evidence — every human, animal, and lab study, graded — is one tap away: use the See the deeper science → toggle at the top.
Typical dosing
Talk to your medical provider before starting any protocol. That said, here are the doses most people commonly use — shared for educational purposes so you can have an informed conversation. These peptides are sold for research use only and are not FDA-approved drugs, and this isn't medical advice.
What should I avoid combining — and what's synergistic?
Melanotan 1 Community Reports doesn't have a dedicated stacking protocol in our notes — the interactions that matter most are in the safety section above. For how people combine it with other peptides, the deeper-science view has the full detail.
How can I buy this?
We don't have a verified affiliate source for Melanotan 1 Community Reports yet, so there's no coupon or vendor link here — we won't point you to a seller we haven't vetted. When buying any research-use-only peptide, the single biggest variable is the supply chain: insist on a vendor that publishes third-party Certificates of Analysis (COAs) confirming identity and >99% purity. Working with a peptide-literate clinician is one solid route — see our provider directory — or check back as our verified sources list grows.
Wiki article — community perspective
Companion raw digest:
Evidence tier: throughout
Last updated: 2026-07-10
Cross-refs: *peptides/melanotan-2* · *peptides/pt-141*
Who reports the strongest results
Two populations with strong, consistent results:
-
Fair-skinned users who normally only burn — MT-I “unlocks tanning” for users who genetically struggle to produce melanin with UV exposure alone.
-
People managing photosensitivity conditions — particularly PMLE (polymorphic light eruption) and related sun-sensitivity disorders. MT-I is FDA-approved as Scenesse for EPP (erythropoietic protoporphyria); the PMLE community uses it off-label with similar logic.
What the community actually says
MT-I vs MT-II — the key distinction
The community distinguishes these two sharply:
| Melanotan I | Melanotan II | |
|---|---|---|
| Receptor selectivity | MC1R selective | MC1R + MC3R + MC4R |
| Tan speed | 18–28 days | 7–12 days |
| Tan color | Natural, gradual | Deep, fast |
| Sexual effects | None | Pronounced (erections, libido) |
| Nausea incidence | Mild | Significant (50–90%) |
| Completion rate | ~90% | ~35% |
| Safety profile | Cleaner | More complex |
Community recommendation: MT-I for cosmetic tanning with safety prioritized, no sexual effects desired, or for women. MT-II for the fastest and darkest result when sexual effects are acceptable or desired.
The tanning experience
- Tan develops gradually with UV exposure over 18–28 days — UV exposure is required; MT-I does not tan without light
- Users describe achieving tans they’ve never been able to achieve naturally — “I tanned for the first time in my life” is a recurring account from fair/red-headed users
- Natural-looking color described as the key aesthetic advantage over MT-II’s sometimes “orange” or artificial appearance
- Reduced burning with the same UV exposure — the increased melanin provides some natural photoprotection
No sexual side effects — the defining advantage
For many community members, this is the entire reason to choose MT-I over MT-II. No spontaneous erections, no libido changes, no unwanted sexual activation. Particularly relevant for women users and for anyone who found MT-II’s sexual effects unwanted.
Protocol as used by the community
Loading: 250 mcg SubQ every 2–3 days for 2–4 weeks, with UV exposure 2–3 hours post-injection
Maintenance: 250–500 mcg every 5–7 days once tan established; continue with UV exposure
UV requirement: 15–20 minutes of natural sunlight or tanning bed 2–3 hours after injection is the typical protocol. Without UV, minimal melanin production.
Mole monitoring: Photograph all existing moles before starting; check monthly during use. Moles darken with melanocyte stimulation — this is expected and consistent. The monitoring is about change in shape/border/color pattern, not just darkening.
Side effects
Mild profile — milder than MT-II across all categories.
- Nausea — present but milder than MT-II; early; dose-dependent; manageable
- Flushing — common; mild; early
- Fatigue — early; typically resolves
- Mole darkening — universal; expected; not a side effect per se, but important to document
- No sexual effects at standard doses
PMLE / photosensitivity application (Kim Pratt account)
Kim Pratt’s documented protocol for managing PMLE: gradual UV introduction (starting with very short exposures) combined with MT-I coverage. Result: meaningful reduction in PMLE flare frequency and improved outdoor tolerance. This account circulates in photosensitivity communities as a reference for off-label MT-I use.
Cross-references
*peptides/melanotan-2*— the faster, deeper, more complex alternative*peptides/pt-141*— the sexual-desire peptide for users who want melanocortin-pathway effects without tanning
Commercial note
Melanotan I is available through Alyve — use code OHM-15 at checkout for 15% off.